Kristin Hodous | Senior Manager, Investor Relations |
Jeff Albers | Chief Executive Officer |
Christy Rossi | Chief Commercial Officer |
Mike Landsittel | Chief Finance Officer |
Andy Boral | Chief Medical Officer |
Marion Dorsch | Chief Scientific Officer |
Terence Flynn | Goldman Sachs |
Joseph Thome | Cowen and Company |
Charles Zhu | Guggenheim Securities |
David Nierengarten | Wedbush Securities |
Andrew Berens | SVB Leerink |
Benedict Shim | Canaccord |
David Leibowitz | Morgan Stanley |
Eun Yang | Jefferies |
Good morning, and welcome to the Blueprint Medicines First Quarter 2019 Financial and Operating Results Conference Call. My name is Carla, I'll be your conference operator today. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. [Operator Instructions] Thank you.